Navigation Links
BRCA2 gene now connected to lung cancer, doubling a smoker's risk
Date:6/2/2014

New research confirms a vulnerability to lung cancer can be inherited and implicates the BRCA2 gene as harboring one of the involved genetic mutations. An international consortium of scientists including investigators at the Institute for Cancer Research in London, the International Agency for Research on Cancer in Lyon, the National Cancer Institute in Bethesda, Harvard, and Dartmouth used integrated results from the 1000 Genomes Project with genetics studies of lung cancer to complete the investigation published on June 1, 2014 in Nature Genetics.

The study scanned the genomes of more than 11 thousand individuals of European descent to look for common variations associated with non-small cell carcinoma, a common form of lung cancer. The analysis showed that variations in the BRCA2 and CHEK2 genes can significantly increase an individual's risk for lung cancer. A smoker's chances of developing lung cancer may be doubled if he or she carries the BRCA2 variation. In addition, the TP63 gene, which previously was only associated with lung cancer risk in Asian populations, was associated with risk for adenocarcinoma, a form of non-small cell carcinoma, in those of European descent.

The study used four genome-wide association (GWA) studies from the U.T. M.D. Anderson Cancer Center, the Institute of Cancer Research, the National Cancer Institute, and the International Agency for Research on Cancer. Scientists used imputation, a statistical form of inference, in which data from a reference set of individuals who have been sequenced is used to fill in missing values on the genome for the study participants. The study validated the use of this approach in finding common genetic variations between multiple sets of data and by extensively genotyping additional participants from Harvard, the International Agency for Research in Cancer, the University of Toronto, the Institute of Cancer Research, and the German Cancer Research Institute.

Chris Amos, PhD, senior author of the paper and director of the Center for Genomic Medicine at Dartmouth said, "This variant confers one the strongest associations found to date for cancer among those identified by genome-wide association studies, and identifies a subset of people who are particularly susceptible to harm associated with smoking."

The BRCA2 gene codes for a very large protein that functions primarily for coordinating activities of many different genes involved in DNA repair. Cells accumulate DNA damage as a result of environmental toxins such as those contained in tobacco smoke. Mutations in BRCA2 may affect the ability of cells to respond to DNA damage, increasing the chance that a cell will become a cancer.

Previous studies did not detect a connection between BRCA2 and lung cancer. All four GWA data set analyses in this study showed significant association of the BRCA2 gene (rs11571833) with non-small cell carcinoma, specifically squamous cell carcinoma. In addition, results validated previous studies connecting CHEK2 (rs17879961) with squamous cell carcinoma. The findings of the TP63 (rs13314271) variation in individuals in European ancestry provides robust evidence for its connection to adenocarcinoma.

"Our study showed that mutations to two genes, BRCA2 and CHEK2, have a very large effect on lung cancer risk in the context of smoking. Mutated BRCA2 in particular seems to increase risk by around 1.8 times," said study leader Richard Houlston, professor of Molecular and Population Genetics at The Institute of Cancer Research (ICR). "Smokers in general have nearly a 15 per cent chance of developing lung cancer, far higher than in non-smokers. Our results show that some smokers with BRCA2 mutations are at an enormous risk of lung cancer somewhere in the region of 25 per cent over their lifetime. Lung cancer claims more than a million lives a year worldwide and is by far the biggest cancer killer in the UK. We know that the single biggest thing we can do to reduce death rates is to persuade people not to smoke, and our new findings make plain that this is even more critical in people with an underlying genetic risk."

The results of this study may influence how individuals are screened and treated for lung cancer. Those with genetic mutations who smoke may be candidates for lung cancer screening with low-dose CT scans. Since individuals with germline mutations of BRCA1 or BRCA2 respond to a specific chemotherapy called PARP inhibition, it is possible that individuals with this BRCA2 mutation and lung cancer may similarly respond more favorably to PARP inhibition than other lung cancer cases.


'/>"/>

Contact: Robin Dutcher
Robin.dutcher@hitchcock.org
603-653-9056
The Geisel School of Medicine at Dartmouth
Source:Eurekalert

Related medicine news :

1. Researchers identify mechanism of cancer caused by loss of BRCA1 and BRCA2 gene function
2. Fulgent Therapeutics Announces Their Comprehensive Hereditary Cancer Test Including BRCA1 and BRCA2 Analysis
3. Ottawa researchers find new pathway connected to type 2 diabetes
4. Health and wealth connected?
5. Meditab Software’s IMSGo™ Mobile EHR App Keeps Physicians Connected
6. Dr. Gary Gordon, Ed.D., Bluewater International Managing Partner, to be Significant Contributor at Activate Networks 3rd Annual Connected Insight Summit
7. Mobile Health Apps Market: 80% Revenue of mHealth Market Dominated by Connected Medical Devices Segment Says a New Report Available at RnRMarketResearch.com
8. New Survey Findings: Application Intelligence and Connected Devices - How do you Harness the Value?
9. Nexus Connected Healthcare Debuts on the 2013 Healthcare Informatics Top 100 List
10. Z-Connector Presents Devices at M-Enabling Summit to Help Users Stay Connected
11. CyraCom Wins TripleTree iAward for Connected Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology: